Teva Pharmaceutical Industries Ltd
TASE:TEVA
Teva Pharmaceutical Industries Ltd
Cash from Investing Activities
Teva Pharmaceutical Industries Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Cash from Investing Activities
$968m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Cash from Investing Activities
$148.1m
|
CAGR 3-Years
373%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Cash from Investing Activities
-₪147.2m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-286%
|
CAGR 10-Years
-74%
|
Mediwound Ltd
NASDAQ:MDWD
|
Cash from Investing Activities
-$34.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-28%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Cash from Investing Activities
-₪20.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-15%
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Cash from Investing Activities
-₪1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Teva Pharmaceutical Industries Ltd's Cash from Investing Activities?
Cash from Investing Activities
968m
USD
Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Cash from Investing Activities amounts to 968m USD.
What is Teva Pharmaceutical Industries Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-12%
Over the last year, the Cash from Investing Activities growth was 48%. The average annual Cash from Investing Activities growth rates for Teva Pharmaceutical Industries Ltd have been 4% over the past three years , -12% over the past five years .